The Food and Drug Administration generally approves vaccines when their benefits outweigh their risks for their intended use. A paper in the journal Health Affairs that was published today reviews current and potential approaches to this critical role of the FDA.
The paper can be obtained at https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.01620.